ArticleMolecular biomedicine2026
Zebrafish dspb-/- mutant as a model for non-dilated left ventricular cardiomyopathy: exploring cardiac dysfunction and exercise modulation.
Article in Molecular biomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Truncating variants in the DSP gene are associated with non-dilated left ventricular cardiomyopathy (ND-LVC), characterized by impaired ventricular function without dilation. The influence of physical activity in disease onset, severity, and progression in DSP variant carriers remains unclear. This study aimed to generate a zebrafish model carrying a human DSP truncating variant to characterize homozygous dspb-/- mutants in terms of cardiac function, structure, and gene expression. The impact of moderate and endurance exercise was additionally evaluated. Clinical data from human carriers were also analysed to assess the relationship between physical activity, age at diagnosis, disease severity and arrhythmic events. A CRISPR/Cas9-generated dspb-/- zebrafish model (p.T449fs*) was used to characterize structural, functional, and molecular phenotypes. Moderate exercise training protocols were applied to assess their effect on cardiac function, endurance capacity, and survival. Physically active human carriers were diagnosed at a younger age but did not show increased disease severity or events rates. Zebrafish mutants exhibited baseline systolic dysfunction, sarcomeric disorganization, and signaling pathway dysregulation. Importantly, moderate exercise partially restored cardiac function and improved endurance without increasing mortality. These findings indicate that exercise may serve as a phenotypic modifier in DSP-related ND-LVC, enhancing functional outcomes without accelerating disease progression. The dspb-/- zebrafish model provides a robust translational platform to investigate the interactions between lifestyle factors and the pathogenesis of inherited desmosomal cardiomyopathies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.